Save the Date!

IGBA will host its third annual Global Biosimilars Week on November 14-18. The goal of the campaign is to raise awareness of the powerful impact of biosimilar medicines and provide key resources for advocates and interested parties.

Support the Campaign

All week, we invite stakeholders, patients, health care professionals and their organizations around the world to share their resources and information about biosimilar medicines using the hashtag #GlobalBiosimilarsWeek. Together we can create a movement to advance access of biosimilar medicines to patients around the world.
Don't miss out and subscribe to hear the latest news on this campaign.

Strengthening Healthcare
The Value of Biosimilar Medicines

The campaign theme this year is the Value of Biosimilar medicines. Each day of the week we will be focusing on different aspects of providing value for all stakeholders.

Biosimilars: Value for patients
  • Provide increased and sustainable access to quality- assured and cost-effective biologic treatments (high value care), hence contributing to improve the quality of care and hence improved health outcomes
  • Offer greater choice for patients
  • Increase the opportunity of biologic treatments in LMICs, hence supporting health equity (global access)
Biosimilars: Value for healthcare professionals, providers and clinical practice
  • Offer greater choice for healthcare providers / autonomy to prescribe (lifting restrictions)
  • Allow cost savings and efficiencies in the delivery of high-value care
  • Explore earlier interventions in the course of the disease for better outcomes (immunology)
  • Enable access to innovative combination therapies (cancer)
  • Invest in care beyond medicines: staff, equipment, diagnostics and testing
Biosimilars: Value for governments and healthcare systems
  • Increasing access is an essential pillar for governments in achieving Target 3.4 of the UN Sustainable Development Goals SDGs by 2030 – i.e. reduce mortality from Non-Communicable Diseases and promote mental health.
    • help to address inequities in health
  • Introduce competition to the biologics market, which impacts overall treatment costs over time
  • Provide headroom for innovation
  • Support medium and long-term sustainability of healthcare systems
  • Ensure supply chain resilience
Biosimilars: Value for regulators
  • Allow vast global positive clinical experience with biologic medicines, confirmed through consistency of pharmacovigilance
  • Foster science and refinements of comparability technologies
  • Converge and harmonize regulatory requirements
Join the Biosimilars Movement!
  • When competition with biosimilars kicks in, there are no policies supporting the reinvestment of the savings into more patients having access.n
    Suzette Kox, IGBA Secretary Generaln

  • With 15 years of positive biosimilar medicines contribution to patient health and healthcare system sustainability, the challenges and remedies to efficient use of biosimilar medicines are well known.n
    Julie Maréchal-Jamil, Co-Chair, IGBA Biosimilars Committee

  • The COVID-19 global health crisis has led governments and the entire healthcare community to rethink and rebuild healthcare systems; this includes focusing on their ability to efficiently deliver access to biologic therapies and to effectively address non-communicable diseases.n
    Sudarshan Jain, IGBA Imminent Past Chair

#GlobalBiosimilarsWeek Around the Globe

View organizations or activities helping to build a better future with biosimilar medicines.

Are You Participating in Global Biosimilars Week?

To add a biosimilars related event or link on the global map, submit the form below.

Organization Name



Congratulations. Your message has been sent successfully.
Error, please retry. Your message has not been sent.

Join the IGBA GBW LinkedIn event and connect with others:

Have a look at the 2022 theme in the video below and join the movement!


Share this video


Media Partners

Meet our media partners and learn about the important work they are doing to raise awareness about biosimilars.

Become a Media Partner!

We are looking for media publications who can help extend the reach of the Global Biosimilars Week campaign. Raise your company profile and help educate stakeholders by participating in this annual awareness campaign. Media partners will be included on the website and in communications and marketing prior and during the event. Learn more about the partner benefits and join the movement!

For more information contact


Email Address

Congratulations. Your message has been sent successfully.
Error, please retry. Your message has not been sent.

C/O DYN SA - Rue de Cornavin 11 - 1201 Geneva, Switzerland
Telephone: +32 (0)477438729 (S. Kox)